Skip to main content
. Author manuscript; available in PMC: 2012 Jun 15.
Published in final edited form as: Clin Cancer Res. 2011 May 9;17(12):3924–3932. doi: 10.1158/1078-0432.CCR-10-3120

Figure 4.

Figure 4

Expression profile of prostate cancer biomarker genes ( AMACR, ERG, KLK3, PCA3, and TMPRSS2:ERG fusion) in the bone metastatic tissues as assessed by quantitative RT-PCR. Log 2 fold change in Target gene/GAPDH is plotted with all samples normalized to the PREC control sample.